Artificial cationic peptides that increase nuclease resistance of siRNA without disturbing RNAi activity-Reference-Cited by-同舟云学术

Artificial cationic peptides that increase nuclease resistance of siRNA without disturbing RNAi activity

Published:2019-01-19 Issue:5 Volume:38 Page:338-348
ISSN:1525-7770
Container-title:Nucleosides, Nucleotides & Nucleic Acids
language:en
Short-container-title:Nucleosides, Nucleotides & Nucleic Acids

Author:

Maeda Yusuke¹,Iwata Hara Rintaro¹²^ORCID,Nishina Kazutaka²,Yoshida-Tanaka Kie²,Sakamoto Taiichi³,Yokota Takanori²,Wada Takeshi¹^ORCID

Affiliation:

1. Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan;

2. Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan;

3. Faculty of Advanced Engineering, Chiba Institute of Technology, Narashino, Chiba, Japan

Funder

Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, Japan

Publisher

Informa UK Limited

Subject

Genetics,Molecular Medicine,Biochemistry,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15257770.2018.1543890

Reference24 articles.

1. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

2. RNA interference: From gene silencing to gene-specific therapeutics

3. The therapeutic potential of RNA interference

4. RNA interference in the clinic: challenges and future directions

5. Small silencing RNAs: an expanding universe

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA/RNA heteroduplex technology with cationic oligopeptide reduces class-related adverse effects of nucleic acid drugs;Molecular Therapy - Nucleic Acids;2024-09

2. Properties of artificial cationic oligodiaminosaccharides and oligopeptides that bind to A-type oligonucleotide duplexes;Nucleosides, Nucleotides & Nucleic Acids;2023-02-27

3. New Molecular Technologies for Oligonucleotide Therapeutics-2: A-Type Nucleic Acid Duplex-Specific Binding Oligocationic Molecules for Oligonucleotide Therapeutics;Handbook of Chemical Biology of Nucleic Acids;2023

4. New Molecular Technologies for Oligonucleotide Therapeutics-2: A-Type Nucleic Acid Duplex-Specific Binding Oligocationic Molecules for Oligonucleotide Therapeutics;Handbook of Chemical Biology of Nucleic Acids;2022-12-24